Nov 14, 2024 04:10PM
Aug 13, 2024 04:10PM
May 15, 2024 04:10PM
Apr 30, 2024 08:00AM
Apr 16, 2024 05:29PM
Mar 26, 2024 04:10PM
Mar 12, 2024 04:15PM Panbela to Host Fourth Quarter and Year End 2023 Earnings Conference Call on March 26, 2024
Feb 15, 2024 08:01AM
Feb 15, 2024 08:00AM
Jan 30, 2024 08:15AM
Jan 29, 2024 06:15AM
Jan 29, 2024 06:15AM
Jan 25, 2024 07:00AM
Jan 18, 2024 08:16AM Panbela (PBLA) announces publication of clinical data from studies of CPP-1X in neuroblastoma
Jan 18, 2024 08:15AM
Dec 21, 2023 09:16AM
Dec 21, 2023 09:15AM
Dec 18, 2023 08:16AM
Dec 18, 2023 08:15AM
Dec 4, 2023 08:00AM
Nov 29, 2023 08:15AM Panbela Announces 2nd Independent Safety Review of the ASPIRE Registration Clinical Trial: Recommended Continuation with no Trial Modification
Nov 9, 2023 04:10PM
Nov 3, 2023 07:55AM
Nov 3, 2023 07:55AM
Nov 2, 2023 08:20AM
Nov 2, 2023 08:15AM
Oct 31, 2023 08:15AM
Oct 31, 2023 08:15AM Panbela Announces Validation of European Patent in UK, Italy, Germany, France, and Spain for Claims of a Novel Process for the Production of SBP-101
Oct 25, 2023 08:15AM
Oct 24, 2023 08:15AM
Sep 26, 2023 08:16AM
Sep 26, 2023 08:15AM
Sep 19, 2023 08:15AM
Sep 5, 2023 08:15AM
Sep 5, 2023 08:15AM Panbela Announces Issuance of New Patent in Chile for Claims of a Novel Process for the Production of Flynpovi
Aug 28, 2023 08:15AM
Aug 14, 2023 08:15AM
Aug 14, 2023 08:15AM
Aug 10, 2023 04:10PM
Jul 31, 2023 04:15PM
Jul 24, 2023 08:15AM
Jul 19, 2023 08:00AM Panbela Therapeutics to Receive a Total Up to $9.5 Million for Divestiture of Assets within Eflornithine (DFMO) Pediatric Neuroblastoma Program to US WorldMeds
Jul 17, 2023 06:00AM
Jul 10, 2023 08:15AM
Jul 10, 2023 08:15AM
Jun 28, 2023 08:16AM
Jun 28, 2023 08:15AM
Jun 26, 2023 08:15AM
Jun 13, 2023 08:16AM Panbela Therapeutics (PBLA) Enters Research Agreement for Polyamine Metabolic Inhibitor Therapy in Combination with CAR-T Cell Therapy
Jun 13, 2023 08:15AM

322,245 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All